Search

everythinglearnresearchcommunity

for

Search:↓

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ustekinumab helped three kids with alopecia areata regrow hair.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

The rash resolved after stopping ponatinib.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

CS12192 effectively treats alopecia areata with better safety than current options.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Ruxolitinib can cause a delayed skin reaction on the nose.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.